Detalles de la búsqueda
1.
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.
Clin Infect Dis
; 75(3): 390-398, 2022 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34940806
2.
A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
Clin Infect Dis
; 70(1): 1-10, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31125055
3.
Phase 3 Safety and Immunogenicity Study of a Three-dose Series of Twenty-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers.
Pediatr Infect Dis J
; 43(6): 587-595, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38456705
4.
A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants.
Int J Infect Dis
; 141: 106942, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38242195
5.
A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adultsâ¯≥â¯60 years of age in Japan, South Korea, and Taiwan.
Vaccine
; 42(5): 1071-1077, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38267330
6.
A Phase 3, Single-arm Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Healthy Children 15 Months Through <18 Years of Age.
Pediatr Infect Dis J
; 43(6): 574-581, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38502894
7.
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Infants.
Pediatr Infect Dis J
; 43(6): 596-603, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38535409
8.
Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial.
Vaccine
; 41(13): 2137-2146, 2023 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36828719
9.
Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugate vaccine in adults ≥65 years old.
Vaccine
; 41(28): 4190-4198, 2023 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244809
10.
Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trial.
Hum Vaccin Immunother
; 19(2): 2245727, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37927075
11.
Case Report: A Case of Late-Onset Combined Methylmalonic Acidemia and Hyperhomocysteinemia Induced by a Vegetarian Diet.
Front Pediatr
; 10: 896177, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35903162
12.
Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease.
Hum Vaccin Immunother
; 18(6): 2126253, 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368038
13.
A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States.
Hum Vaccin Immunother
; 17(7): 2249-2256, 2021 07 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33545022
14.
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination.
Vaccine
; 39(51): 7494-7502, 2021 12 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34839993
15.
Safety and immunogenicity of different Clostridioides (Clostridium) difficile vaccine formulations in two early phase randomized studies of healthy adults aged 50-85 years.
Vaccine
; 39(40): 5991-6003, 2021 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34483022
16.
Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States.
Pediatr Infect Dis J
; 40(10): 944-951, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34525007
17.
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial.
Lancet Infect Dis
; 21(2): 263-274, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32891191
18.
Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.
Curr Alzheimer Res
; 14(7): 696-708, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28124589
19.
Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.
J Alzheimers Dis
; 51(4): 1131-43, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26967206
20.
A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults.
Vaccine
; 34(18): 2082-91, 2016 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26993331